Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12555769 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAABCC4MAPT | |
| SCHEMBL12555791 | 1.00 | ALDH1A1 (0.35) | ALDH1A1LMNAABCC4MAPT | |
| SCHEMBL12555789 | 0.95 | ALDH1A1 (0.39) | ALDH1A1LMNAABCC4MAPT | |
| SCHEMBL12555775 | 0.95 | ALDH1A1 (0.39) | ALDH1A1LMNAABCC4MAPT | |
| SCHEMBL20049545 | 0.95 | ALDH1A1 (0.39) | ALDH1A1LMNAABCC4MAPT | |
| SCHEMBL17035915 | 0.92 | TSHR (0.31) | — | |
| SCHEMBL19004027 | 0.92 | TSHR (0.31) | — | |
| SCHEMBL24548555 | 0.85 | ALDH1A1 (0.36) | ALDH1A1LMNAABCC4MAPT | |
| SCHEMBL21424367 | 0.85 | ALDH1A1 (0.36) | ALDH1A1LMNAABCC4MAPT | |
| SCHEMBL21128890 | 0.85 | ALDH1A1 (0.36) | ALDH1A1LMNAABCC4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022129630-A1 | G PROTEIN PEPTIDOMIMETICS | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2022-06-23 | — | — | WO | disclosed |
| US-20220177522-A1 | PROLINE-LOCKED STAPLED PEPTIDES AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-06-09 | — | — | US | disclosed |
| US-11332496-B2 | Stapled and stitched polypeptides and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-05-17 | — | — | US | disclosed |
| US-10919936-B2 | — | — | 2021-02-16 | — | — | US | disclosed |
| US-20190202862-A1 | STAPLED AND STITCHED POLYPEPTIDES AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2019-07-04 | — | — | US | disclosed |
| US-10301351-B2 | Stitched polypeptides | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-05-28 | — | — | US | disclosed |
| US-20180100001-A1 | BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10301351-B2 | Stitched polypeptides | VIP, IAPP, NGLY1 | ALDH1A1 4098/4885LMNA 3761/4885ABCC4 3682/4885 |
| US-20220177522-A1 | PROLINE-LOCKED STAPLED PEPTIDES AND USES THEREOF | PRAP1, PRR12, NPPA | ALDH1A1 3816/4885LMNA 570/4885ABCC4 4429/4885 |
| US-20180100001-A1 | BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF | TIMCC, SPPL2B, SCTR | ALDH1A1 4639/4885LMNA 3970/4885ABCC4 4468/4885 |
| US-10919936-B2 | — | VIP, NGLY1, F12 | ALDH1A1 4506/4885LMNA 189/4885ABCC4 1333/4885 |
| US-20190202862-A1 | STAPLED AND STITCHED POLYPEPTIDES AND USES THEREOF | VIP, NGLY1, IAPP | ALDH1A1 4451/4885LMNA 391/4885ABCC4 3035/4885 |
| US-11332496-B2 | Stapled and stitched polypeptides and uses thereof | VIP, NGLY1, IAPP | ALDH1A1 4451/4885LMNA 391/4885ABCC4 3035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.